The efficacy and safety of vonoprazan in quadruple therapy for Helicobacter pylori eradication: a comparative study
{{output}}
Background: The efficacy and optimal dose of the new acid-suppressant vonoprazan (VPZ) for quadruple therapy remain uncertain. This study aimed to compare the efficacy and safety of 20 mg VPZ daily (VOD) and 20 mg VPZ twice daily... ...
